Northway Biotech
Andrius Vaitkus has a diverse work experience spanning different industries. Andrius currently holds the position of Head of Finance at Northway Biotech since 2021. Prior to that, they worked at Swedbank from 2017 to 2021 as a Corporate Segment Analysis Area Manager. Before joining Swedbank, they served as a Credit Analyst at Euler Hermes Suomi from 2015 to 2017. Andrius also gained experience as a Risk Analyst at Investment and Business Guarantees, Ltd from 2013 to 2015. Earlier in their career, they worked at Swedbank as a Risk & Capital Analyst and later as an Analyst at Credit Risk Control department. Andrius started their professional journey at Deloitte Lithuania as an Audit Assistant, where they gained skills in balance sheet analysis, team working, and client relationships.
Andrius Vaitkus completed their Bachelor's degree in Economics at The University of Manchester from 2005 to 2008. Andrius then pursued a Master's degree in Financial Economics at ISM University of Management and Economics from 2013 to 2015. In 2018, they obtained a certification in "Become a Manager" from LinkedIn.
This person is not in any teams
Northway Biotech
Northway Biotech is a Contract Development and Manufacturing Organization (CDMO) located in Waltham, MA, USA, and Vilnius, Lithuania, EU. Extensive expertise in drug substance and drug product development, as well as GMP compliant manufacturing, makes us exceptionally well-versed in all aspects of the biopharmaceutical value chain – from gene to drug manufacturing in microbial and mammalian expressions systems. Our customers appreciate our ability to react rapidly to unexpected project changes, adjusting timelines, and availability of additional capabilities to meet our customers' evolving needs. We are deeply invested in providing high-quality, world-class contract development and manufacturing services with vast flexibility and responsiveness backed by a strong foundation in science and technology innovation. Northway Biotech end-to-end services include: Cell Line (Mammalian & Microbial) Development Analytical Methods Development Formulation Development Upstream & Downstream Process Development (USP & DSP) cGMP Manufacturing of Biologics & Biosimilars (Drug Substance, Drug Product) cGMP Master and Working Cell Bank Manufacturing cGMP pDNA Manufacturing Fill & Finish (F&F) Quality Assurance, Quality Control, and Regulatory CMC Support